BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1636018)

  • 1. Primary aldosteronism and hyperandrogenism.
    Macrì C; Gregianin M; Bui F
    Rays; 1992; 17(1):49-61. PubMed ID: 1636018
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenocortical scintigraphy.
    Troncone L; Danza FM
    Rays; 1992; 17(1):34-9. PubMed ID: 1636016
    [No Abstract]   [Full Text] [Related]  

  • 3. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism.
    Kao CH; Liao SQ; Wang SJ; Lin MS; Hsu CY; Lin WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Apr; 8(4):213-8. PubMed ID: 1578517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiocholesterol scintigraphy in Cushing's syndrome.
    Rufini V; Saletnich I; Troncone L
    Rays; 1992; 17(1):40-8. PubMed ID: 1636017
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. III. Comparative studies of baseline and dexamethasone suppression imaging in aldosteronism.
    Nakajo M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):380-8. PubMed ID: 7122228
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging the adrenal cortex: why and wherefore?
    Britton KE
    Nucl Med Commun; 1992 Jul; 13(7):485-7. PubMed ID: 1495676
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.
    Kazerooni EA; Sisson JC; Shapiro B; Gross MD; Driedger A; Hurwitz GA; Mattar AG; Petry NA
    J Nucl Med; 1990 Apr; 31(4):526-34. PubMed ID: 2324830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on adrenal scanning agents, 131I-adosterol (author's transl)].
    Yonahara Y; Takahara Y; Sasaki Y; Kirimura H; Sato A
    Radioisotopes; 1977 Feb; 26(2):102-5. PubMed ID: 577028
    [No Abstract]   [Full Text] [Related]  

  • 9. [Suppression of adrenal function by dexamethasone in radionuclide differential diagnosis of hyperaldosteronism].
    Ametov AS; Kramer AA; Abashidze RI
    Med Radiol (Mosk); 1980 Apr; 25(4):58-63. PubMed ID: 7382761
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adrenal scanning in primary aldosteronism].
    Kubo A; Kobayashi T; Isobe Y; Dokiya T; Hiramatsu K
    Rinsho Hoshasen; 1975 Jan; 20(1):31-8. PubMed ID: 1169404
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
    Gordon L; Levine JH; Mayfield RK; Buse MG
    J Nucl Med; 1979 Aug; 20(8):897-8. PubMed ID: 541739
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical application of dexamethasone suppression adrenal scintiscan of the adrenal glands in congenital adrenal hyperplasia].
    Yen TC; Liu RS; Yeh SH
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Apr; 41(4):287-92. PubMed ID: 3179816
    [No Abstract]   [Full Text] [Related]  

  • 13. Scintigraphic localization of ovarian dysfunction.
    Mountz JM; Gross MD; Shapiro B; Barkan AL; Woodbury MC; Schteingart DE; Ayers JW
    J Nucl Med; 1988 Oct; 29(10):1644-50. PubMed ID: 3171694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary aldosteronism. CT, MRI, scintigraphic correlation.
    Velchik MG; Kressel HY; Noel AW; Alavi A
    Invest Radiol; 1985; 20(3):237-41. PubMed ID: 3897117
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)].
    Leger FA; Requeda E; Reach G; Plouin PF; Savoie JC
    Nouv Presse Med; 1981 Feb; 10(6):395-9. PubMed ID: 7220332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The possible sources of hyperandrogenism in hirsutism in girls].
    Semicheva TV; Kolesnikova GS; Pishchulin AA; Pankova SS; Dobracheva AD; Martysh NS
    Probl Endokrinol (Mosk); 1990; 36(5):53-5. PubMed ID: 1964216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
    Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
    Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol.
    Hogan MJ; McRae J; Schambelan M; Biglieri EG
    N Engl J Med; 1976 Feb; 294(8):410-4. PubMed ID: 1246308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observation of 12 cases of primary aldosteronism, special reference to the diagnostic problem (author's transl)].
    Hata S; Kunita H; Okamoto M; Kadena N; Obara T; Ito Y; Nakagawa K; Suzuki H; Nakagawa S
    Hokkaido Igaku Zasshi; 1980 Sep; 55(5):379-88. PubMed ID: 7016700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal scintigraphy in primary aldosteronism.
    Sundsfjord JA; Jorgensen H; Sander S
    Scand J Urol Nephrol; 1974; 8(3):227-9. PubMed ID: 4428187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.